ArticleInternational journal of antimicrobial agents2021

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.

Marion Plaze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.